Statements (66)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Oncology
|
| gptkbp:can_detect |
mammography
|
| gptkbp:can_metastasize_to |
lymph nodes
|
| gptkbp:can_recur_after |
initial treatment
|
| gptkbp:diagnosis |
clinical evaluation
biopsy women of various ages |
| gptkbp:has_a_focus_on |
breast cancer advocacy
|
| gptkbp:has_hormone_receptor |
progesterone receptor
|
| https://www.w3.org/2000/01/rdf-schema#label |
PR-positive breast cancer
|
| gptkbp:is_affected_by |
lifestyle factors
|
| gptkbp:is_associated_with |
gptkb:tamoxifen
lifestyle changes increased screening rates lower mortality rates better prognosis increased estrogen levels |
| gptkbp:is_characterized_by |
specific genetic markers
high levels of progesterone receptors hormonal receptor positivity hormonal sensitivity response to hormonal therapy |
| gptkbp:is_common_in |
postmenopausal women
|
| gptkbp:is_diagnosed_using |
molecular testing
|
| gptkbp:is_effective_against |
gptkb:triple-negative_breast_cancer
|
| gptkbp:is_evaluated_by |
immunohistochemistry
|
| gptkbp:is_influenced_by |
environmental factors
socioeconomic factors genetic mutations dietary habits hormonal factors |
| gptkbp:is_linked_to |
patient quality of life
family history of breast cancer |
| gptkbp:is_monitored_by |
follow-up appointments
imaging tests recurrence risk |
| gptkbp:is_often_accompanied_by |
chemotherapy
|
| gptkbp:is_part_of |
breast cancer research
breast cancer support groups breast cancer statistics breast cancer awareness campaigns breast cancer education breast cancer research initiatives breast cancer awareness month activities breast cancer screening programs breast cancer staging breast cancer treatment plans |
| gptkbp:is_recognized_by |
gptkb:guidelines
|
| gptkbp:is_studied_for |
treatment outcomes
|
| gptkbp:is_studied_in |
clinical trials
|
| gptkbp:requires |
gptkb:surgery
|
| gptkbp:scientific_classification |
tumor grade
luminal subtype |
| gptkbp:treatment |
personalized medicine
radiation therapy targeted therapy oncology clinics hormonal therapy adjuvant therapy neoadjuvant therapy medical oncologists aromatase inhibitors hormonal agents |
| gptkbp:type_of |
gptkb:hormone_receptor-positive_breast_cancer
|
| gptkbp:bfsParent |
gptkb:CDK4/6
|
| gptkbp:bfsLayer |
6
|